期刊文献+

Expressions of Beta-Catenin,SUFU and VEGFR-2 Proteins in Medulloblastoma 被引量:1

Expressions of Beta-Catenin,SUFU and VEGFR-2 Proteins in Medulloblastoma
下载PDF
导出
摘要 Objective: to investigate the expressions of beta-catenin, SUFU and VEGFR-2 proteins in medulloblastoma. Methods: Immunohistochemical staining with SP method was conducted to determine the expressions of beta-catenin, SUFU and VEGFR-2 in 33 cases of medulloblastoma and 10 normal cerebellar tissues. Results: the abnormal expression rates of beta-catenin and VEGFR-2 in medulloblastoma were significantly higher than that in normal tissue. While the positive expression of SUFU gene in medulloblastoma was significantly lower than that in 10 normal cerebellar tissues, A significant negative correlation was found between beta-catenin and SUFU proteins and a positive correlation between beta-catenin and VEGFR-2 was found in medulloblastoma. Conclusion: Beta-catenin, VEGFR-2 and SUFU have important effects on the pathogenesis and development of medulloblastoma. Objective: to investigate the expressions of beta-catenin, SUFU and VEGFR-2 proteins in medulloblastoma. Methods: Immunohistochemical staining with SP method was conducted to determine the expressions of beta-catenin, SUFU and VEGFR-2 in 33 cases of medulloblastoma and 10 normal cerebellar tissues. Results: the abnormal expression rates of beta-catenin and VEGFR-2 in medulloblastoma were significantly higher than that in normal tissue. While the positive expression of SUFU gene in medulloblastoma was significantly lower than that in 10 normal cerebellar tissues, A significant negative correlation was found between beta-catenin and SUFU proteins and a positive correlation between beta-catenin and VEGFR-2 was found in medulloblastoma. Conclusion: Beta-catenin, VEGFR-2 and SUFU have important effects on the pathogenesis and development of medulloblastoma.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2007年第4期299-303,共5页 中国癌症研究(英文版)
关键词 Beta-cateuln VEGFR-2 SUFU MEDULLOBLASTOMA Beta-cateuln VEGFR-2 SUFU Medulloblastoma
  • 相关文献

参考文献12

  • 1Frank T. KoUigs, Guido Bommer, Burkhard GSke. Wnt/Beta-catenin/Tcf signaling: A critical pathway in gastrointestinal tumorigenesis[J]. Digestion 2002, 66: 131-44.
  • 2Takemaru KI, Yamaguchi S, Lee YS, et al. A nuclear β-catenin-associated antagonist of the Wnt/wingless pathway[J]. Nature 2003, 422: 905-9.
  • 3Masood R, Cai J, Zheng T, et al. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors[J]. Blood 2001, 98: 1904-13.
  • 4Michael DT, Liu L, Corey R, et al. Mutations in SUFU predispose to medulloblastoma[J]. Nature Genetics 2002,31: 306-10.
  • 5David WE, Olabisi EO, Janet CL, et al. Beta-catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain tumor Committee[J]. J Clin Oncol 2005, 23:7951-7.
  • 6Eberhart CG, Tihan T, Burger PC. Nuclear localization and mutation of β-catenin in medulloblastomas[J]. Neuropathol Exp Neurol 2000, 59: 333-7.
  • 7Kuhnert E Davis CR, Wang HT, et al. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1 [J]. Proc Natl Acad Sci USA 2004,101: 66-71.
  • 8Katrin L, Marc AB, Carmen E, et al. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin[J]. Clin Cancer Res 2005, 11: 4934-40.
  • 9Skurk C, Maatz H, Rocnik E, et al. Glycogen- Synthase Kinase-3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells[J]. Circ Res 2005, 96: 308-18.
  • 10Goodlad RA, Ryan AJ, Wedge SR, et al. Inhibiting vascular endothelial growth factor signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer[J]. Carcinogenesis 2006, 27: 2133-9.

同被引文献31

  • 1Mulhem RK , Palmer SL, Merchant TE, et al. Neurocognitive consequences of risk-adapted therapy forchildhood medulloblastoma [J]. J Clin Oncol, 2005; 23: 5511-5519.
  • 2Ellison DW, Dalton J, Kocak M, et al.Medulloblastoma: clinicopathological correlates of SHH, WNT, and non- SHH/WNT molecular subgroups [J]. Acta Neuropathol, 2011;121:381-396.
  • 3Roussel MF, Hatten ME. Cerebellum development and medulloblastoma [J]. Curr Top Dev Biol, 2011;94:235- 282.
  • 4Rogers HA, Sousa S, Saho C, et al. WNT/β-catenin pathway activation in Myc immortalised cerebellar progenitor cells inhibits neuronal differentiation and generates tumours resembling medulloblastoma [J]. Br J Cancer, 2012;107:1144-1152.
  • 5Grammel D, Warmuth-Metz M, von Bueren AO, et al. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem [J]. Acta Neuropathol, 2012;123:601-614.
  • 6Pilarsky C, Ammerpohl O, Sipos B, et al. Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling [J]. J Cell Mol Med, 2008;12:2823-2835.
  • 7Pacheco-Pinedo EC, Durham AC, Stewart KM, et al. Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium [J]. J Clin Invest, 2011;121:1935-45.
  • 8Matsuda Y, Schlange T, Oakeley E J, et al. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth [J]. Breast Cancer Res, 2009; 11 :R32.
  • 9Shenoy AK, Fisher RC, Butterworth EA, et al. Transition from colitis to cancer: high wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors[J]. Cancer Res, 2012;72:5091-5100.
  • 10Nikuseva-Marti? T, Beros V, Pe?ina-Slaus N, et al. Genetic changes of CDH1, APC, and CTNNB1 found in human brain tumors[J]. Pathol Res Pract, 2007;203:779- 787.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部